BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16818375)

  • 1. Functional coupling of the Galpha(olf) variant XLGalpha(olf) with the human adenosine A2A receptor.
    Ravyn V; Bostwick JR
    J Recept Signal Transduct Res; 2006; 26(4):241-58. PubMed ID: 16818375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the adenosine A
    Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-alpha by equine monocytes.
    Sun WC; Moore JN; Hurley DJ; Vandenplas ML; Linden J; Cao Z; Murray TF
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):91-100. PubMed ID: 17913243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium modulates calmodulin/α-actinin 1 interaction with and agonist-dependent internalization of the adenosine A
    Piirainen H; Taura J; Kursula P; Ciruela F; Jaakola VP
    Biochim Biophys Acta Mol Cell Res; 2017 Apr; 1864(4):674-686. PubMed ID: 28130124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcellular localization of a novel G protein XLGalpha(olf).
    Akita K; Takahashi Y; Kataoka M; Saito K; Kaneko H
    Biochem Biophys Res Commun; 2009 Apr; 381(4):582-6. PubMed ID: 19245791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the A2A adenosine G-protein-coupled receptor by conformational selection.
    Ye L; Van Eps N; Zimmer M; Ernst OP; Prosser RS
    Nature; 2016 May; 533(7602):265-8. PubMed ID: 27144352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a Na
    Noël F; do Monte FM
    J Pharmacol Toxicol Methods; 2017; 84():51-56. PubMed ID: 27810394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
    J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A1 receptors: [35S]GTPgammaS binding studies.
    Ito H; Maemoto T; Akahane A; Butcher SP; Olverman HJ; Finlayson K
    Eur J Pharmacol; 1999 Jan; 365(2-3):309-15. PubMed ID: 9988116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A
    Mediero A; Wilder T; Shah L; Cronstein BN
    FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.
    van der Wenden EM; Carnielli M; Roelen HC; Lorenzen A; von Frijtag Drabbe Künzel JK; IJzerman AP
    J Med Chem; 1998 Jan; 41(1):102-8. PubMed ID: 9438026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A
    Fuentes E; Fuentes M; Caballero J; Palomo I; Hinz S; El-Tayeb A; Müller CE
    Platelets; 2018 May; 29(3):292-300. PubMed ID: 28504052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J; Luo LY; Li JG; Chen C; Liu-Chen LY
    J Pharmacol Exp Ther; 1997 Aug; 282(2):676-84. PubMed ID: 9262330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allosteric modulation and constitutive activity of fusion proteins between the adenosine A1 receptor and different 351Cys-mutated Gi alpha-subunits.
    Klaasse E; de Ligt RA; Roerink SF; Lorenzen A; Milligan G; Leurs R; IJzerman AP
    Eur J Pharmacol; 2004 Sep; 499(1-2):91-8. PubMed ID: 15363955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylation of sulfhydryl groups on Galpha(s/olf) subunits by N-ethylmaleimide: regulation by guanine nucleotides.
    Giusti L; Taddei S; Ceccarelli F; Chericoni S; Bigini G; Lucacchini A; Mazzoni MR
    Biochim Biophys Acta; 2003 Jun; 1613(1-2):7-14. PubMed ID: 12832082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanosine-Mediated Anxiolytic-Like Effect: Interplay with Adenosine A
    Frinchi M; Verdi V; Plescia F; Ciruela F; Grillo M; Garozzo R; Condorelli DF; Di Iorio P; Caciagli F; Ciccarelli R; Belluardo N; Di Liberto V; Mudò G
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-2 adrenergic receptor functional coupling to G proteins in rat brain during postnatal development.
    Happe HK; Bylund DB; Murrin LC
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1134-42. PubMed ID: 10027851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
    Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic control of guanine nucleotide binding to soluble Galpha(q).
    Chidiac P; Markin VS; Ross EM
    Biochem Pharmacol; 1999 Jul; 58(1):39-48. PubMed ID: 10403517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.